Answers are grounded in this paper and cite their sources.
Guillain-Barré syndrome (GBS) is an autoimmune-mediated acute polyneuropathy that can progress to life-threatening respiratory failure. The diagnosis and treatment of this pathology are complicated by the rarity of the disease and diversity in clinical presentation due to rarer, more dangerous subtypes of GBS. Understanding the time course of progression from onset to nadir of neurological deficits, maintaining a high index of suspicion, and close airway monitoring are essential in rapid diagnosis, securing the airway, and treatment.
No takes yet. Share an insight, caveat, or question.
Neumeister et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: